These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37986879)

  • 1. Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study.
    Alba C; Malhotra S; Horsfall S; Barnhart ME; Bekker A; Chapman K; Cunningham CK; Fast PE; Fouda GG; Freedberg KA; Goga A; Ghazaryan LR; Leroy V; Mann C; McCluskey MM; McFarland EJ; Muturi-Kioi V; Permar SR; Shapiro R; Sok D; Stranix-Chibanda L; Weinstein MC; Ciaranello AL; Dugdale CM
    medRxiv; 2023 Nov; ():. PubMed ID: 37986879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings.
    Dugdale CM; Ufio O; Alba C; Permar SR; Stranix-Chibanda L; Cunningham CK; Fouda GG; Myer L; Weinstein MC; Leroy V; McFarland EJ; Freedberg KA; Ciaranello AL
    J Int AIDS Soc; 2023 Jan; 26(1):e26052. PubMed ID: 36604316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis.
    Dunning L; Gandhi AR; Penazzato M; Soeteman DI; Revill P; Frank S; Phillips A; Dugdale C; Abrams E; Weinstein MC; Newell ML; Collins IJ; Doherty M; Vojnov L; Fassinou Ekouévi P; Myer L; Mushavi A; Freedberg KA; Ciaranello AL
    J Int AIDS Soc; 2021 Jan; 24(1):e25651. PubMed ID: 33474817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.
    Ouattara EN; MacLean RL; Danel C; Borre ED; Gabillard D; Huang M; Moh R; Paltiel AD; Eholié SP; Walensky RP; Anglaret X; Freedberg KA
    PLoS One; 2019; 14(6):e0219068. PubMed ID: 31247009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model-based analysis to inform paediatric HIV screening programmes.
    McCann NC; Stanic T; Penazzato M; Flanagan CF; Abrams EJ; Dugdale CM; Johnson LF; Neilan AM; Davies MA; Freedberg KA; Fassinou P; Doherty M; Essajee S; Mushavi A; Soeteman DI; Ciaranello AL
    J Int AIDS Soc; 2022 Dec; 25(12):e26045. PubMed ID: 36519674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
    Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
    AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study.
    Frank SC; Cohn J; Dunning L; Sacks E; Walensky RP; Mukherjee S; Dugdale CM; Turunga E; Freedberg KA; Ciaranello AL
    Lancet HIV; 2019 Mar; 6(3):e182-e190. PubMed ID: 30737187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa.
    Dugdale CM; Phillips TK; Myer L; Hyle EP; Brittain K; Freedberg KA; Cunnama L; Walensky RP; Zerbe A; Weinstein MC; Abrams EJ; Ciaranello AL;
    PLoS One; 2019; 14(11):e0225104. PubMed ID: 31730630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.
    Ciaranello AL; Doherty K; Penazzato M; Lindsey JC; Harrison L; Kelly K; Walensky RP; Essajee S; Losina E; Muhe L; Wools-Kaloustian K; Ayaya S; Weinstein MC; Palumbo P; Freedberg KA
    AIDS; 2015 Jun; 29(10):1247-59. PubMed ID: 25870982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
    Losina E; Touré H; Uhler LM; Anglaret X; Paltiel AD; Balestre E; Walensky RP; Messou E; Weinstein MC; Dabis F; Freedberg KA; ;
    PLoS Med; 2009 Oct; 6(10):e1000173. PubMed ID: 19859538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.
    Venkatesh KK; Becker JE; Kumarasamy N; Nakamura YM; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP; Freedberg KA
    PLoS One; 2013; 8(5):e64604. PubMed ID: 23741348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
    Goldie SJ; Yazdanpanah Y; Losina E; Weinstein MC; Anglaret X; Walensky RP; Hsu HE; Kimmel A; Holmes C; Kaplan JE; Freedberg KA
    N Engl J Med; 2006 Sep; 355(11):1141-53. PubMed ID: 16971720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d'Ivoire Modeling Analysis.
    Neilan AM; Cohn J; Sacks E; Gandhi AR; Fassinou P; Walensky RP; Kouadio MN; Freedberg KA; Ciaranello AL
    Open Forum Infect Dis; 2021 Jun; 8(6):ofab225. PubMed ID: 34189169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.
    Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA
    Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency.
    Francke JA; Penazzato M; Hou T; Abrams EJ; MacLean RL; Myer L; Walensky RP; Leroy V; Weinstein MC; Parker RA; Freedberg KA; Ciaranello A
    J Infect Dis; 2016 Nov; 214(9):1319-1328. PubMed ID: 27540110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.
    Luz PM; Osher B; Grinsztejn B; Maclean RL; Losina E; Stern ME; Struchiner CJ; Parker RA; Freedberg KA; Mesquita F; Walensky RP; Veloso VG; Paltiel AD
    J Int AIDS Soc; 2018 Mar; 21(3):e25096. PubMed ID: 29603888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.
    Reddy KP; Gupta-Wright A; Fielding KL; Costantini S; Zheng A; Corbett EL; Yu L; van Oosterhout JJ; Resch SC; Wilson DP; Horsburgh CR; Wood R; Alufandika-Moyo M; Peters JA; Freedberg KA; Lawn SD; Walensky RP
    Lancet Glob Health; 2019 Feb; 7(2):e200-e208. PubMed ID: 30683239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness.
    Bassett IV; Govindasamy D; Erlwanger AS; Hyle EP; Kranzer K; van Schaik N; Noubary F; Paltiel AD; Wood R; Walensky RP; Losina E; Bekker LG; Freedberg KA
    PLoS One; 2014; 9(1):e85197. PubMed ID: 24465503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe.
    Ciaranello AL; Perez F; Engelsmann B; Walensky RP; Mushavi A; Rusibamayila A; Keatinge J; Park JE; Maruva M; Cerda R; Wood R; Dabis F; Freedberg KA
    Clin Infect Dis; 2013 Feb; 56(3):430-46. PubMed ID: 23204035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.
    Ouattara EN; Ross EL; Yazdanpanah Y; Wong AY; Robine M; Losina E; Moh R; Walensky RP; Danel C; Paltiel AD; Eholié SP; Freedberg KA; Anglaret X
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):294-302. PubMed ID: 24732870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.